Aliada Therapeutics

Allyx

This clinical-stage biotechnology company develops oral small molecule therapies to protect synapses in patients with Alzheimer's disease and other neurodegenerative conditions.

Korsana Biosciences

This biotechnology company develops brain-penetrant therapeutics for patients with neurodegenerative conditions such as Alzheimer's disease.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.

MindImmune

This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.

Revivio Therapeutics

This clinical-stage biotechnology company develops small molecule therapeutics for patients with neurodegenerative diseases, including Alzheimer's disease and mild cognitive impairment.